Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$76.44 USD

76.44
7,374,533

-0.11 (-0.14%)

Updated Sep 17, 2025 04:00 PM ET

After-Market: $76.50 +0.06 (0.08%) 7:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (93 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Trina Mukherjee headshot

6 MedTech Stocks That are Set to Beat the Market in 2020

by Trina Mukherjee

Banking on the three key trends, we zero in on six MedTech stocks that are likely to deliver stellar performance in 2020.

Zacks Equity Research

Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (DXCM) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Here's Why You Should Add DexCom (DXCM) to Your Portfolio

by Zacks Equity Research

DexCom (DXCM) raises its 2019 revenue and EPS guidance.

Zacks Equity Research

DexCom (DXCM) Up 16.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

DexCom (DXCM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (DXCM) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

The Zacks Analyst Blog Highlights: DexComm, Forterra, Vista Outdoor, Hibbett Sports and Target

by Zacks Equity Research

The Zacks Analyst Blog Highlights: DexComm, Forterra, Vista Outdoor, Hibbett Sports and Target

Zacks Equity Research

DexCom, Inc. (DXCM) Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor DexCom, Inc. (DXCM).

Zacks Equity Research

5 Best Bets in View Before the Curtain Falls on November

by Zacks Equity Research

Solid economic data, favorable earnings reports and subsiding trade war anxiety bump up stocks in November. Here are top five momentum stocks that are poised to grow.

Nalak Das headshot

6 Top Momentum Stocks in November With More Room to Run

by Nalak Das

A temporary trade truce between the United States and China will bolster business confidence and stabilize overall U.S. economic growth.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for November 29th

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 29th

David Bartosiak headshot

5 Screaming Hot Strong Buy Stocks

by David Bartosiak

Do not let this pullback opportunity pass you by as the market has plenty of room to run.

Trina Mukherjee headshot

Digital Diabetes Management Gains Momentum: 3 Stocks in Focus

by Trina Mukherjee

With digital diabetes management space rapidly gaining momentum, patients with diabetes can look forward to better and improved outcomes.

Zacks Equity Research

The Zacks Analyst Blog Highlights: DexCom, Forterra, NeoPhotonics, Ironwood and Cardtronics

by Zacks Equity Research

The Zacks Analyst Blog Highlights: DexCom, Forterra, NeoPhotonics, Ironwood and Cardtronics

Nalak Das headshot

5 Best-Performing, Top-Ranked Growth Stocks of November

by Nalak Das

Wall Street's impressive bull run is likely to continue in the near term. At this stage, it will be prudent to invest in growth stocks with a favorable Zacks Rank.

Zacks Equity Research

5 Growth Stocks to Buy as U.S.-China Trade Tiff Eases

by Zacks Equity Research

The United States and China finally seem to be making progress on a phase one deal. Here are our five top growth stocks that are poised for fair returns.

Zacks Equity Research

MEDNAX (MD) Ties Up With Homestead to Expand in Florida

by Zacks Equity Research

MEDNAX (MD) collaborates with Associated Pediatricians of Homestead to provide clinical services and expand presence in Florida.

Zacks Equity Research

Dexcom (DXCM) Hits a 52-Week High: What's Driving the Stock?

by Zacks Equity Research

Dexcom (DXCM) gains from several positive developments.

Trina Mukherjee headshot

Digital Health Gaining Momentum: 3 MedTech Stocks in Focus

by Trina Mukherjee

Digital health is committed to changing the face of healthcare as evident from its innovative solutions for the betterment of patients' lives.

Zacks Equity Research

Earnings Estimates Moving Higher for DexCom (DXCM): Time to Buy?

by Zacks Equity Research

DexCom (DXCM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

The Zacks Analyst Blog Highlights: comScore, Communications Systems, Vista Outdoor, Forterra and DexCom

by Zacks Equity Research

The Zacks Analyst Blog Highlights: comScore, Communications Systems, Vista Outdoor, Forterra and DexCom

Zacks Equity Research

5 Winning Stocks Halfway Through Q4

by Zacks Equity Research

We have highlighted stocks that have done well so far in the fourth quarter and have room to scale higher in the near future.

Zacks Equity Research

BD's Onclarity HPV PMA Submission to Boost Women's Health

by Zacks Equity Research

Becton, Dickinson (BDX) offers a wide range of next-generation solutions in the field of cervical, ovarian and breast cancer.

Zacks Equity Research

San Gorgonio Hospital Picks Allscripts Sunrise Community Care

by Zacks Equity Research

Allscripts' (MDRX) Sunrise Community Care is an Azure-hosted platform offering clinical, financial and ambulatory content.

Sanghamitra Saha headshot

Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

by Sanghamitra Saha

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

Zacks Equity Research

NextGen's Medfusion Buyout to Improve Patient Experience

by Zacks Equity Research

NextGen (NXGN) showcases new capabilities and services for its flagship NextGen Enterprise platform.